Literature DB >> 26438485

Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma: a Letter to Response.

Wei Liu1, Jian-Guo Zhou2, Bao-Cai Xing3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26438485     DOI： 10.1007/s11605-015-2966-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  14 in total

1.  Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes.

Authors:  Shimul A Shah; Paul D Greig; Steven Gallinger; Mark S Cattral; Elijah Dixon; Robin D Kim; Bryce R Taylor; David R Grant; Charles M Vollmer
Journal:  J Am Coll Surg       Date:  2005-12-19       Impact factor: 6.113

2.  Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.

Authors:  R Ciria; P López-Cillero; A-B Gallardo; J Cabrera; M Pleguezuelo; M-D Ayllón; A Luque; L Zurera; J-J Espejo; M Rodríguez-Perálvarez; J-L Montero; M de la Mata; J Briceño
Journal:  Eur J Surg Oncol       Date:  2015-06-12       Impact factor: 4.424

3.  Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

Authors:  Chin-Ta Lin; Kuo-Feng Hsu; Teng-Wei Chen; Jyh-Cherng Yu; De-Chuan Chan; Chih-Yung Yu; Tsai-Yuan Hsieh; Hsiu-Lung Fan; Shih-Ming Kuo; Kuo-Piao Chung; Chung-Bao Hsieh
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

4.  Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Authors:  Jian-hong Zhong; Yang Ke; Wen-feng Gong; Bang-de Xiang; Liang Ma; Xin-ping Ye; Tao Peng; Gui-sheng Xie; Le-qun Li
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

5.  Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.

Authors:  E Adachi; T Maeda; K Kajiyama; N Kinukawa; T Matsumata; K Sugimachi; M Tsuneyoshi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

Review 6.  Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

Authors:  Luigi Bolondi; Andrew Burroughs; Jean-François Dufour; Peter R Galle; Vincenzo Mazzaferro; Fabio Piscaglia; Jean Luc Raoul; Bruno Sangro
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

7.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

8.  Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.

Authors:  Shao-Liang Zhu; Yang Ke; Yu-Chong Peng; Liang Ma; Hang Li; Le-Qun Li; Jian-Hong Zhong
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

9.  Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Authors:  Jian-Hong Zhong; Bang-De Xiang; Wen-Feng Gong; Yang Ke; Qin-Guo Mo; Liang Ma; Xing Liu; Le-Qun Li
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.